Andy Lane

Life science consultant, 30 yrs experience of supplying antibodies and proteins to the research and IVD markets.

[Andy Lane @AndyLaneLifeSci]

@EricTopol @Cell_Metabolism Your summary on this isn’t strictly accurate is it? Even a quick read of the abstract shows that 5:2 has some benefits over the healthy living diet. They’re not big differences, but to say there are no differences is misleading.

[Andy Lane @AndyLaneLifeSci]

@MartinSLewis I’m surprised she didn’t say “ if you leave out energy costs inflation only rose to 4%”.

[Andy Lane @AndyLaneLifeSci]

@DrNeilStone I’m always surprised by the lack of understanding. It really seems that people think we will eradicate this like Smallpox. The other major Coronaviruses have been around for hundreds of years, and this will be too.

[Andy Lane @AndyLaneLifeSci]

@ToTheHappyNone Starlight Barking by Stekpanna

[Andy Lane @AndyLaneLifeSci]

@DrNeilStone It’s worse than confirmation bias - this article is frightening and really important for anyone in this platform. Can you believe anything you read?

[Andy Lane @AndyLaneLifeSci]

Found a copy of this 1956 Immunology text book in a “pre-loved” shop in the New Forest today. I’m not sure who was more surprised, me for finding it or the shopkeeper for finding a buyer! I’m going to enjoy reading this and reminding myself what we’ve…https://t.co/RNve0IfbY8

[Andy Lane @AndyLaneLifeSci]

Glykogen are proud to announce the availability of their new rabbit IgG monoclonal antibody recognising Stage-specific embryonic antigen-4 (SSEA-4). SSEA-4 is a ganglioside which consists of a glycosphingolipid containing a terminal sialic acid residue (N…https://t.co/xoCk8TLeoN

[Andy Lane @AndyLaneLifeSci]

Great balanced thread on the debate about COVID origins. Refreshing on this platform to see both sides of an argument given consideration

[Jeremy Konyndyk @JeremyKonyndyk]

Core problem is this: there's no real evidence for lab origin, but due to China's obfuscation, it can't be definitively refuted either. So it become a sort of Rorschach test that hinges on your priors.

[Andy Lane @AndyLaneLifeSci]

Some important context on Flu in Australia this year

[Karen Cutter @KarenCutter4]

Influenza in Australia in 2022.
A thread/
I'm writing this thread as, according to a friend travelling in Europe, there is a lot of sensationalist reporting about what a bad flu season we had in Australia in 2022.

[Andy Lane @AndyLaneLifeSci]

A great article on Covid booster shots. Well worth a read. To boost or not to boost - by Eric Topol - Ground Truths https://t.co/scvDkYdqpC @EricTopol

[Andy Lane @AndyLaneLifeSci]

The "one size fits all" approach to vaccination seems a little blunt as a weapon against COVID now. Can we understand better who needs a booster?

[Attomarker @Attomarker]

UK announced COVID-19 vaccine boosters heading into winter

Is it the right vaccine to use?
Who should be prioritised?
Are you still protected and how can you check?

Find out more in the LinkedIn article below:
https://t.co/mXHgw7kMEa

[Andy Lane @AndyLaneLifeSci]

Now of course we know that the conspiracy theorists won't agree - but.........The Huanan Seafood Wholesale Market in Wuhan was the early epicenter of the COVID-19 pandemic https://t.co/1YssHbGuUF

[Andy Lane @AndyLaneLifeSci]

First approval in the UK for an Omicron specific vaccine. How effective will this be against the BA.4 and BA.5 variants, and will we all have been infected anyway by the time this is rolled out?

[James Gallagher @JamesTGallagher]

Covid: UK approves Moderna's Omicron booster with tackles the variant and the original https://t.co/exdmAvQNDr

[Andy Lane @AndyLaneLifeSci]

Extensive study by the Iwasaki and Putrino groups, really beginning to get some immunological data on #LongCovid. Some very interesting findings to follow up on

[Prof. Akiko Iwasaki @VirusesImmunity]

Very excited to share our latest research on immunological features of #LongCovid. Our 2+ year collaboration with @PutrinoLab with many other fantastic colleagues and patients - Mount Sinai Yale Long COVID (MY-LC) study by @sneakyvirus1 et al. 🧵(1/)

https://t.co/8cGj51HyGn

[Andy Lane @AndyLaneLifeSci]

Confirmation that #Omicron variants avoid antibody responses and may escape the frontline monoclonal antibody treatments #SARSCoV2

[Andy Lane @AndyLaneLifeSci]

A very interesting article, well worth a read. Nicely balanced, but clearly points out that SARS-CoV-2 will be evolving for a long time to come. We need to keep monitoring, and be ready to adjust responses based on real data

[Fred Hutch Cancer Center @fredhutch]

“There’s not a lot of things I’m confident about in SARS-CoV-2 evolution, but I think I’m extremely confident we’ll keep seeing new variants that are progressively eroding antibody neutralization," said Fred Hutch virologist Jesse Bloom (@jbloom_lab). https://t.co/TK8zq1OvoF

[Andy Lane @AndyLaneLifeSci]

@IndependentSage @chrischirp @Zubhaque @DeenanDpillay If, like me, you’ve known more people who have had #Covid_19 since “Freedom Day” a year ago than before that day, you’ll be interested in reading this

[Andy Lane @AndyLaneLifeSci]

@FortisLifeSci continue to build an exciting portfolio of life science businesses with their acquisition of Abcore, the nanobody specialists from San Diego.

[Andy Lane @AndyLaneLifeSci]

@BIVDA I’m sorry BIVDA, but this is both remarkably late and very weak in tone. It’s also poorly written. Our diagnostic industry deserves better

[Andy Lane @AndyLaneLifeSci]

Huge deal for @PeproTech with their acquisition by @thermofisher confirmed at $1.85B